Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $20.6950 (1.87%) ($20.6950 - $20.6950) on Mon. Feb. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.97% (three month average) | RSI | 62 | Latest Price | $20.6950(1.87%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.9% a day on average for past five trading days. | Weekly Trend | ATRA advances 3.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.985% in a week (0% probabilities). VIXM(-35%) VXX(-27%) UNG(-10%) UUP(-9%) TLT(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.985% (StdDev 3.97%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $19.79(4.57%) | 10 Day Moving Average | $19.39(6.73%) | 20 Day Moving Average | $19.16(8.01%) | To recent high | -21.4% | To recent low | 44.2% | Market Cap | $1.538b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |